Cosmo Pharmaceuticals N.V. (COPN.SW) SIX
71.90
-0.6(-0.83%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
71.90
-0.6(-0.83%)
Currency In CHF
| Market Cap | 1.8B |
| Enterprise Value | 1.75B |
| P/E Ratio | -346.25 |
| PEG Ratio | 3.37 |
| Price/Sales Ratio | 12.16 |
| Price/Book Ratio | 2.59 |
| Enterprise/Revenue | 11.66 |
| Enterprise/EBITDA | 172.59 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.03 |
| Operating Margin | -0.05 |
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
| Revenue | 104.85M |
| Revenue/Share | 6.53 |
| Gross Profit | 48.78M |
| EBITDA | 2.36M |
| Net Income | -3.63M |
| Diluted EPS | -0.23 |
| Total Cash | 122.66M |
| Total Cash/Share | 7.68 |
| Total Debt | 4.26M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 7.18 |
| Book Value Per Share | 30.61 |
| 52-Week Change | 29.78 |
| 52-Week High | 129.4 |
| 52-Week Low | 53.4 |
| Moving Average 50 Days | 83.21 |
| Moving Average 200 Days | 85.14 |
| Average Volume | 55,278 |
| Shares Outstanding | 16.19M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2.09 |
| Trailing Annual Dividend Yield | 2.67 |
| Payout Ratio | -8.99 |
| Last Split Factor | N/A |
| Last Split Date | N/A |